Stocksigma LogoStocksigma Logo

Strides Pharma Science Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 14,297 (+17.1% YoY | +13.0% QoQ) ■ EBITDA: 2,509 (+8.4% YoY | +9.2% QoQ) ■ EBITDA Margin (%): 17.5 (-142 bps YoY | -61 bps QoQ) ■ PAT: 1,308

Strides Pharma Science Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Strides Pharma Science Ltd · Outcome · 30 Oct 2026, 12:13 am

Strides Pharma Science Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 14,297 (+17.1% YoY | +13.0% QoQ) ■ EBITDA: 2,509 (+8.4% YoY | +9.2% QoQ) ■ EBITDA Margin (%): 17.5 (-142 bps YoY | -61 bps QoQ) ■ PAT: 1,308 (+2.6% YoY | -16.6% QoQ) ■ EPS (INR): 14.2 (+2.5% YoY | -16.6% QoQ)

Original exchange filing (PDF)

More announcements from Strides Pharma Science Ltd

All Strides Pharma Science Ltd announcements